Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/15897
Title: Diagnosing 'Male Depression' in prostate cancer patients: The next step in translational psycho-oncology interventions?
Contributor(s): Sharpley, Christopher  (author)orcid ; Bitsika, Vicki  (author); Christie, David R H  (author)
Publication Date: 2014
DOI: 10.1002/pon.3530
Handle Link: https://hdl.handle.net/1959.11/15897
Abstract: Background: Depression in men diagnosed with prostate cancer is associated with several adverse outcomes. However, some data suggest that standard methods of assessing depression in males via the criteria for Major Depressive Disorder (MDD) may omit several extra key symptoms of male depression. Therefore, this study tested the comparative effects of standard MDD-based diagnostic criteria for depression and criteria for 'male depression' in a sample of men diagnosed with prostate cancer. Method: 191 men diagnosed with prostate cancer completed a postal survey questionnaire containing questions about background variables, the Patient Health Questionnaire-9 for depression (PHQ9) and the Gotland Male Depression Scale (GMDS). Comparisons were made of the relative prevalence of depression according to these scales, plus a scale that combined the PHQ9 and GMDS extra items for male depression. Results: Although there were significant correlations between total PHQ9 and GMDS scores, over one-third of variance in the GMDS was not accounted for by the PHQ9, and sensitivity of the PHQ9 against the GMDS showed that about 24% of those patients identified as depressed on the GMDS would not be similarly identified on the PHQ9. Different prevalence rates from the two scales suggested that they were assessing different sets of symptoms of depression. A combined PHQ9-GMDS scale of 15 items was used to produce a profile of male depression in these patients. Conclusion: Adequate and reliable assessment of depression in men diagnosed with prostate cancer may require use of additional symptoms to those listed for MDD, and treatment planning and delivery could be more precise and effective using this methodology.
Publication Type: Journal Article
Source of Publication: Psycho-Oncology, 23(9), p. 1042-1048
Publisher: John Wiley & Sons Ltd
Place of Publication: United Kingdom
ISSN: 1099-1611
1057-9249
Fields of Research (FoR) 2008: 110319 Psychiatry (incl Psychotherapy)
Fields of Research (FoR) 2020: 320903 Central nervous system
Socio-Economic Objective (SEO) 2008: 920111 Nervous System and Disorders
Socio-Economic Objective (SEO) 2020: 200409 Mental health
Peer Reviewed: Yes
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Appears in Collections:Journal Article

Files in This Item:
2 files
File Description SizeFormat 
Show full item record

SCOPUSTM   
Citations

18
checked on Jul 6, 2024

Page view(s)

1,244
checked on May 19, 2024
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.